Replies to post #2658 on Fibrocell Science Inc (FCSC)

[ANTADOG]

Not me, i read fda approval, and i buy , simple as that, quick look at the rsi tells me there is lotsof room, imo of course, ANT

[Wrinkles]

Doesn't matter what happened at this point, question is this:

Is retail out and buying can take over and push this up?

OR

Are the preferreds done selling if that is who it is, so this can start back up?

My profile states I'm a flipper, so that is what I do on almost all my stocks, rarely do I ever hold long term, not my bag in this eroding economy, to each his own though.

[goodstok]

THE ANSWER TO ALL YOUR QUESTIONS? IS IT?
QUOTE:

It looks like my post about FCSC three weeks ago was spot-on. From #msg-63888868:
Quote:
--------------------------------------------------------------------------------
…I don’t especially care if laViv gets FDA approval on June 22 (or any other date); the salient point is that laViv does not satisfy an unmet medical need and is destined to be a commercial bust.

I had this kind of discussion with iHub posters who were wildly bullish about SOMX’s Silenor and DDSS’ Oleptro. These stocks were heavily pumped on iHub (as FCSC surely is now), the companies got FDA approval, the drugs are utterly inconsequential in the commercial marketplace, and the former pumpers are MIA. FCSC will follow the same script, IMO…
--------------------------------------------------------------------------------

Although you will probably argue vociferously that the company has a great future, behind closed doors you probably feel that you were conned: you took a huge risk, the drug got FDA approval, but the share price is a big yawn. Eventually, you will have to admit (privately, if not publicly) that this drug has no chance whatsoever to capture more than a minuscule share of the market for aesthetic medicine.